BUPROPION HYDROCHLORIDE

Generic: BUPROPION HYDROCHLORIDE

Sun Pharmaceutical IndustriesManufacturer
ORALRoute
BUPROPION HYDROCHLORIDEActive Substance
2014-12-18Original Approval

BUPROPION HYDROCHLORIDE is FDA application ANDA200695, sponsored by SUN PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2025-09-15
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceu

Failed Tablet/Capsule Specifications

Class II2024-06-24
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only,

Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

Class III2013-11-15
BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count b

Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.

Class III2018-03-15
buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC 69097-

Failed Dissolution Specifications; during stability testing

Class III2018-03-15
buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc.

Failed Dissolution Specifications; during stability testing

Class II2022-12-27
BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health P

Failed Impurities/Degradation Specifications

Class II2021-03-15
bupropion Hydrochloride Tablets, USP 75 mg 100 Tablets Rx only NDC 23155-191-01 Manufactured for: Heritage Pharmaceutica

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Class III2018-09-06
Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for: Cip

Failed impurities/ degradation specifications: Out-of-specification results were observed in the met

Class II2023-12-29
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Ph

Presence of Foreign Tablets/Capsules

Top Reported Reactions

1
DRUG INEFFECTIVE
2,373 reports
2
HEADACHE
1,683 reports
3
FATIGUE
1,541 reports
4
DEPRESSION
1,527 reports
5
NAUSEA
1,402 reports
6
OFF LABEL USE
1,193 reports
7
PAIN
1,082 reports
8
ANXIETY
1,041 reports
9
INTENTIONAL OVERDOSE
1,002 reports
10
RASH
901 reports